PUBLISHER: The Business Research Company | PRODUCT CODE: 1948316
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948316
Surgical soft tissue forceps are specialized tools used during operations to grasp, hold, and manipulate soft tissues with minimal damage. They feature fine tips and a gentle grip to carefully handle delicate tissues.
There are two main types of surgical soft tissue forceps disposable and reusable. Disposable forceps are intended for single use, typically made from cost-effective materials suitable for one procedure, particularly in environments where hygiene and contamination are critical, such as sterile settings or surgeries involving infectious diseases. These forceps are used in hospitals, clinics, and other medical facilities. End users include professionals in gynecology, general surgery, neurosurgery, plastic surgery, and other fields.
Tariffs are impacting the surgical soft tissue forceps market by increasing costs of imported stainless steel, titanium alloys, precision machining equipment, and surface coating materials used in disposable and reusable forceps manufacturing. Hospitals and surgical centers in North America and Europe are most affected due to dependence on imported medical-grade metals and components, while Asia-Pacific faces cost pressure on export-oriented instrument production. These tariffs are increasing procurement costs and affecting pricing strategies for healthcare providers. However, they are also encouraging localized manufacturing, regional supplier development, and investments in domestic production capabilities for surgical instruments.
The surgical soft tissue forceps market research report is one of a series of new reports from The Business Research Company that provides surgical soft tissue forceps market statistics, including surgical soft tissue forceps industry global market size, regional shares, competitors with a surgical soft tissue forceps market share, detailed surgical soft tissue forceps market segments, market trends and opportunities, and any further data you may need to thrive in the surgical soft tissue forceps industry. This surgical soft tissue forceps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The surgical soft tissue forceps market size has grown strongly in recent years. It will grow from $1.38 billion in 2025 to $1.48 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing volume of surgical procedures, expansion of hospital infrastructure, wider availability of advanced surgical instruments, growing emphasis on patient safety standards, rising adoption of minimally invasive surgeries.
The surgical soft tissue forceps market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for disposable surgical instruments, rising focus on infection prevention, expansion of outpatient surgical procedures, growing adoption of advanced material coatings, increasing healthcare spending on surgical tools. Major trends in the forecast period include increasing demand for precision surgical instruments, rising adoption of single-use surgical forceps, growing focus on ergonomic instrument design, expansion of corrosion-resistant forceps materials, enhanced emphasis on sterility and infection control.
The rising number of aesthetic procedures is expected to propel the growth of the surgical soft tissue forceps market going forward. Aesthetic procedures are elective medical treatments, surgical or non-surgical, aimed at enhancing an individual's physical appearance. The growth in these procedures is driven by evolving beauty standards, increased accessibility to cosmetic treatments, and social media trends emphasizing appearance enhancement. Surgical soft tissue forceps are crucial in aesthetic surgeries, enabling surgeons to handle delicate tissues precisely, minimize trauma, and ensure accurate placement during procedures such as facelifts, rhinoplasties, and breast augmentations. For instance, in June 2025, the International Society of Aesthetic Plastic Surgery Inc., a US-based nonprofit organization, reported in its 2024 Global Survey that 17.4 million surgical aesthetic procedures and 20.5 million non-surgical aesthetic procedures were performed worldwide in 2024, totaling nearly 38 million procedures. Therefore, the rising number of aesthetic procedures is driving the growth of the surgical soft tissue forceps market.
The rising preference for minimally invasive surgeries is expected to propel the growth of the surgical soft tissue forceps market going forward. Minimally invasive surgeries are medical procedures performed through small incisions using specialized instruments and imaging techniques to minimize tissue damage. This preference is driven by factors such as faster recovery times, shorter hospital stays, reduced postoperative pain, and a lower risk of complications compared to traditional open surgeries. Surgical soft tissue forceps support these procedures by enabling precise removal of abnormal tissues, such as polyps or tumors, through small incisions. Their design allows adequate tissue resection while minimizing damage to surrounding structures, improving procedural safety and effectiveness. For instance, in June 2024, the American Society of Plastic Surgeons, a US-based professional society representing plastic surgeons, reported a 7% increase in minimally invasive procedures from 2022 to 2023 in the USA. Therefore, the growing preference for minimally invasive surgeries is driving the surgical soft tissue forceps market.
In January 2024, Stille AB, a Swedish firm specializing in the development and production of surgical instruments, purchased Fehling Instruments GmbH & Co. KG and its affiliated subsidiaries for $40.32 million. This acquisition aims to broaden Stille AB's range of premium medical instruments, focusing on specialized surgical fields such as open and minimally invasive procedures in cardiac, thoracic, neurosurgery, and spine surgery. Fehling Instruments GmbH & Co. KG, based in Germany, is known for manufacturing surgical instruments, including soft tissue forceps, enhancing Stille AB's capabilities in these critical surgical specialties.
Major companies operating in the surgical soft tissue forceps market are Medtronic plc, Johnson & Johnson MedTech, Medline Industries, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, CooperSurgical Inc., Cook Medical, Karl Storz GmbH And Co. KG, Integra LifeSciences Corporation, ConMed Corporation, KLS Martin Group, Aesculap Inc., Richard Wolf GmbH, Aspen Surgical Products Inc., Symmetry Surgical Inc., MedGyn Products Inc., Scanlan International Inc., Sklar Surgical Instruments, GPC Medical Ltd., Hayden Medical Inc., Millennium Surgical Corp., S Murray And Co Ltd., Surgmed Group, Lawton GmbH And Co. KG, Marina Medical Instruments Inc., Surgipro Inc., Surtex Instruments Ltd.
North America was the largest region in the surgical soft tissue forceps market in 2025. The regions covered in the surgical soft tissue forceps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the surgical soft tissue forceps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The surgical soft tissue forceps market consists of sales of products such as adson forceps, deBakey forceps, bishop-harmon forceps, and brown-adson forceps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Surgical Soft Tissue Forceps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses surgical soft tissue forceps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for surgical soft tissue forceps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical soft tissue forceps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.